Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller of Pfizer Inc., reported the acquisition of 87 phantom stock units through the Pfizer Supplemental Savings Plan on March 15, 2024.

Summary

• On March 15, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 87 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $27.94.
• Following the reported transaction, Ms. Damico directly owns 27,635 shares.
• The phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not inherently convey positive or negative sentiment. It simply reports a transaction.

Positives

• The acquisition of phantom stock units through the Pfizer Supplemental Savings Plan aligns the executive's interests with those of the shareholders.
• The plan allows for diversification as the units can be transferred to an alternative investment account.

Future Outlook

The document does not contain any specific forward-looking statements regarding Pfizer's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their alignment with shareholder interests.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding executive compensation and ownership.

Key Dates